NEWSROOM

Latest news updates and events from Texray

10MD granted patent in the USA

The US Patent and Trademark Office (USPTO) granted the Ten Medical Design AB (10MD) patent application, Radiation Protective Material (US2016060791). This patent describes ways for surgical staff to be protected...

Tue, Mar 19, 19

Two new patent approvals

The Australian Patent Office and the Russian Patent Office have announced that 10MD has obtained granted patents in Australia and Russia. The patents, entitled 'Radiation Protective Material, are within the...

Fri, Jul 27, 18

HeadPeace clinically validated

In a clinical study performed by researchers at Sahlgrenska University Hospital and Halland Regional Hospital, it was shown that HeadPeace reduces the radiation dose to body parts that are currently...

Mon, Dec 04, 17

10MD in the news (in Swedish)

Utdrag från MedTechWest artikel: -10MD beviljades 180 ooo SEK från Medtech4Health för att förbereda implementation av ledningssystem för att säkerställa att vi uppfyller ställda kvalitetskrav.Det krävs en viss typ av...

Sat, Nov 25, 17

Vinnova supports 10MD

Vinnova has decided to grant a 10MD application. Medtech4Health, a strategic funding program at Vinnova, has decided to grant a 10MD funding application. “We are thrilled to receive this important...

Tue, Oct 31, 17

10MD attracts capital

10MD has raised capital in a funding round from selected private investors. The funding will primarily be used to scale up production capacity of TeXray. Ten Medical Design AB (10MD)...

Tue, Jun 13, 17

TeXray fulfils formal technical requirements

According to conformity tests at the Physikalisch-Technische Bundesanstalt, TeXray fulfils the technical requirements of the standard EN 61331-1. Ten Medical Design AB (10MD) is a medical technology company committed to...

Tue, Feb 21, 17

10MD receives funding from Swelife

10MD has received funding from the Swedish Innovation Programme for Life Science, SWElife. The funding will primarily be used to support 10MD market access activities. Ten Medical Design AB (10MD)...

Wed, Oct 12, 16

10MD attracts private equity

Ten Medical Design AB (10MD) has raised 1M SEK in a funding round to a few selected private investors and Almi Företagspartner AB, owned by the Swedish government. The funding...

Mon, Aug 01, 16

10MD receives funding from Vinnova

Ten Medical Design (10MD) receives additional funding from Vinnova, the Swedish governmental agency for innovation systems. Sweden is dependent on new innovative development based companies, which can become future growth...

Wed, Dec 09, 15

Grant of patent application

The Swedish Patent- and Registration Office (PRV) has decided to grant Ten Medical Design AB (10MD) patent application SE537818 for TeXray (NAFT) radiation protective textile material. X-ray imaging has during...

Wed, Oct 07, 15

10MD receives additional funding

Ten Medical Design (10MD) receives funding from Swerea IVF. Swerea Group, a Swedish industrial research group that encompasses Sweden's industrial research institutes within the fields of materials, process, product and production...

Sat, Nov 01, 14

10MD strengthens team

Ten Medical Design (10MD) strengthens the team to prepare the company to move from a late development stage to a commercialization phase. Mr Zebastian Bohström, PhD in Chemistry, was hired...

Wed, Oct 01, 14

Prototype displayed at Smart Textiles

The first prototype of a radiation protection product, based on the unique material TeXray, is now displayed at Smart Textiles at the University of Borås, Sweden. Smart Textiles is situated...

Tue, Sep 02, 14

10MD receives funding from Vinnova

Ten Medical Design (10MD) receives funding from Vinnova, the Swedish governmental agency for innovation systems. Sweden is dependent on new innovative development-based companies, which can become future growth companies. Vinnova...

Tue, Jun 17, 14

Vinnova funds Ten Medical Design (10MD)

Sweden is dependent on new, innovative development-based companies, which can become future growth companies. Interest from private financing of early-stage companies is usually low as it involves high-risk investments. Vinnova...

Thu, Jun 06, 13

Market research Texray

Respondents included doctors, nurses and technicians in radiology, nuclear medicine, cardiology and surgery from several European countries. The study showed a clear pattern that healthcare staff believe current radiation protection...

Wed, Sep 12, 12